|
ABHD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.655100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.583920E-03 |
| Normal-vs-Stage2 |
7.543000E-01 |
| Normal-vs-Stage3 |
1.479970E-02 |
| Normal-vs-Stage4 |
5.151600E-02 |
| Stage1-vs-Stage2 |
8.758300E-03 |
| Stage1-vs-Stage3 |
8.570200E-01 |
| Stage1-vs-Stage4 |
6.469400E-01 |
| Stage2-vs-Stage3 |
2.608000E-02 |
| Stage2-vs-Stage4 |
5.005900E-02 |
| Stage3-vs-Stage4 |
7.756000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.596240E-03 |
| Normal-vs-AfricanAmerican |
2.422600E-01 |
| Normal-vs-Asian |
7.558900E-03 |
| Caucasian-vs-AfricanAmerican |
4.887400E-01 |
| Caucasian-vs-Asian |
3.477000E-01 |
| AfricanAmerican-vs-Asian |
2.409000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.127800E-01 |
| Normal-vs-Female |
1.544050E-03 |
| Male-vs-Female |
9.624100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.191900E-04 |
| Normal-vs-Age(41-60Yrs) |
7.349800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.264400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.440400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.054050E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.844000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.242600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.473600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.827900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.920400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.736440E-01 |
| Classical-VS-Follicular |
3.022700E-04 |
| Classical-VS-Other |
9.879800E-01 |
| Classical-VS-Normal |
3.997800E-04 |
| Tall-VS-Follicular |
8.378300E-04 |
| Tall-VS-Other |
3.947000E-01 |
| Tall-VS-Normal |
1.190500E-04 |
| Follicular-VS-Other |
2.489200E-01 |
| Follicular-VS-Normal |
8.241400E-01 |
| Other-VS-Normal |
1.260420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.199410E-01 |
| Normal-vs-N1 |
6.278000E-03 |
| N0-vs-N1 |
5.129800E-02 |
|
|
